Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Ono claims selective EP4 receptor ligands and their use

Feb. 24, 2000

L-Nucleoside ribavirin analogues are able to enhance type 1 cytokine production

Feb. 21, 2000

Aventis Pasteur changes focus to second-generation Lyme disease vaccine

Feb. 21, 2000

Biovector Therapeutics and BioChem Pharma to develop S. pneumoniae nasal vaccine

Feb. 21, 2000

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

PDL to humanize Fujisawa antibody

Feb. 17, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

AHP prepares new rapamycin derivatives

Feb. 14, 2000

New immunosuppressive agents derived from LK6-A

Feb. 14, 2000

ID Biomedical's GAS vaccine well tolerated in early clinical testing

Feb. 14, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...